chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After  then 2nd dose of the vaccine  I was experiencing severe pain on my left arm because I was having the lingering pain from the first dose. My pain lasted for more than 3 months. I had disrupted sleep. They refused to put the second dose on the right arm I told them  the left arm was extremely sore an inch of the first dose.  Pain Increased in the injection  site for 3 days  from the second dose. I was experiencing lingering pain from the first dose which increased severely with a bruise. This was the  Unusual pain lasting more than 60 days along with a swollen bruise.  I took  Adil 400 for pain but It didn't help and I also used ice. The pharmacist would not listen to me at all. I even complained about this no one is listening to me at all. Now I am hesitant about getting the 3rd dose. It they force me to get it on the left arm again I am not getting it.
Runny nose; A rash 2 inches below the injection site; Very hot; Red; Bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Very hot), ERYTHEMA (Red), RHINORRHOEA (Runny nose), VACCINATION SITE RASH (A rash 2 inches below the injection site) and HEADACHE (Bad headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 208C21A and 026B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history reported ). Concomitant products included TRAZODONE, TIZANIDINE, OXYBUTYNIN CHLORIDE, TOPIRAMATE, MONTELUKAST SODIUM, ALPRAZOLAM, PANTOPRAZOLE SODIUM, ARIPIPRAZOLE, DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ), ESTRADIOL, VALPROATE SEMISODIUM (DIVALPROEX), GABAPENTIN, TRAMADOL and PRAZOSIN for an unknown indication.   On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jun-2021, the patient experienced HEADACHE (Bad headache). On 29-Jun-2021, the patient experienced FEELING HOT (Very hot), ERYTHEMA (Red) and VACCINATION SITE RASH (A rash 2 inches below the injection site). On an unknown date, the patient experienced RHINORRHOEA (Runny nose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and CORTISONE at a dose of Cream. At the time of the report, FEELING HOT (Very hot), ERYTHEMA (Red), RHINORRHOEA (Runny nose), VACCINATION SITE RASH (A rash 2 inches below the injection site) and HEADACHE (Bad headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
After about 24 hours of receiving the 2nd dose, I had a terrible headache, muscle aches, extreme fatigue.
Patient received PREVNAR vaccine on 02/07/18. Patient called the pharmacy on 2/15/18 stating that she was experiencing local pain. Patient did not report any other side effects. We followed up with patient on 2/16/18 and patient stated she was feeling better and the pain has diminished. We followed up with patient again today (2/19/18). Patient stated that she experienced some radiating over the weekend but the pain has diminished and she is feeling better today.
redness and swollen to inj site, rash to hands Benadryl given for sysmptoms
This spontaneous report as received from a other health professional refers to a 20 year old male patient. On 11-MAY-2017, the patient was vaccinated with a first dose of GARDASIL 9 lot # M035486, expiration date 05-JUN-2019 (route of administration and anatomical location were not reported). On 15-JUN-2017, the patient was vaccinated with a second dose of GARDASIL 9 lot # N001533, expiration date 16-OCT-2019 (route of administration and anatomical location were not reported). The drug was administered to the patient of inappropriate age. No adverse effects were reported. Product quality complaint was not involved. Additional information has been requested.
This case was reported by a consumer and described the occurrence of shingles in a male patient who received SHINGRIX. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles, herpes virus infection, feeling bad, general body pain, fever and influenza-like symptoms. On an unknown date, the outcome of the shingles, herpes virus infection, rash, feeling bad, general body pain, fever and influenza-like symptoms were unknown. It was unknown if the reporter considered the shingles, herpes virus infection, rash, feeling bad, general body pain, fever and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. A few days after the shot, the patient felt badly. Extreme body aches started one morning and that evening the patient had 101 degree fever. The following day the patient still felt fluish. The patient went to physician and she tested for the flu. It was negative, all the symptoms seemed like flu (101 temperature at that night). Next day the Shingle outbreaks started. It had been three weeks and the patient had 5 shingle rashes and more than 10 Herpes outbreaks. The patient was asking what might help his condition. This case was considered as suspected vaccination failure as the time to onset and primary vaccination schedule completion were unknown.
1st shot given on March 9, 2021 2nd Pfizer shot received on March 30, 2021 at same site, also in left arm.  Non-injury swelling began in ankles, moved to legs, arms, hands, neck and face with no known cause other than covid vaccines.
Redness , swelling, itching at the injection site  appeared approximately 7 days after injection.
There was pain, swelling of the arm and body, redness of the entire upper portion of the arm lasting a week including a long blister, a low grade fever lasting three days, muscle aches that traveled throughout the body, tiredness and the strangest headache.
This spontaneous report was received from a medical assistant referring to a 13 year old male patient. The patient's medical history and concurrent conditions were not reported. Concomitant medication included sterile diluent (manufacturer unknown). On 15-MAR-2018, the patient was administered an improperly stored GARDASIL 9 (lot: N026814; Expiry date: 15-JUL-2020 and lot: N021572; Expiry date: 01-MAY-2020) reconstituted with a properly stored sterile diluent (lot and expiry date not reported) for prophylaxis. The vaccine was exposed to 47 °F to 77°F (67.3°F) for 10 hours, 30 minutes. There was no previous temperature excursion. There was no involvement of digital data logger. This is one of the several reports linked via same reporter link.
This spontaneous report as received from a doctor or pharmacy refers to a 58 years old female patient with drug reactions or allergies to "Sulfa" antibiotics and none pertinent medical history. On 23-NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneously (lot number reported as H016230, expiration date unspecified) and levothyroxine sodium. On 25-NOV-2012, the patient developed an injection site reaction that with-in a day spread to the back of her arm with a rash. The injection site reaction was described by the patient to the pharmacist as a red, swollen, hot to the touch area with some discomfort at the injection site. The injection site reaction that spread to the back of the patients arm was described as red, with a rash. The pharmacist could not describe the rash. No treatment was given for adverse events. No laboratory tests were performed. At the time of the report the patient's outcome was reported as not recovered. The relatedness for adverse events was not reported for ZOSTAVAX. The patient sought medical attention, contacted pharmacist (the pharmacist only spoke with the patient on the phone). Additional information has been requested.
Nausea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) and FATIGUE (Fatigue) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced NAUSEA (Nausea) and FATIGUE (Fatigue). On 11-Feb-2021, NAUSEA (Nausea) had resolved. On 13-Feb-2021, FATIGUE (Fatigue) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant details were provided. No treatment details were provided.   This case was linked to MOD-2021-059949 (Patient Link).
On July 30, 2019 at 11 a.m. I received the Shingrix shot in my right deltoid muscle. By mid afternoon I felt nauseated and was unable to eat any food at dinner time At 11 pm. I experienced a piersing headache accompanied by flashing yellow lights and I felt as if my head would explode. I prayed that I would not have a stroke. This pain lasted for a couple of hours. I was cold; my right arm pained from the shoulder down to my fingers; was nauseated and had diarrhea. In getting out of bed I was unsteady and had to grab the bed post to keep from falling.  By 5 a.m. my headache had almost subsided, but I was still nauseated and wobbly on my feet.  After my care-giver arrived in the morning, I called C.D.C. (at 9 a.m) as the vaccine info' statement suggested. I spoke to employee and told her of my reaction to the vaccine. She stated that the adverse reaction would last 3 days and that I should contact my doctor.  I reported this reaction to the nurse in the doctor's office, since my doctor was on vacation. She immediately called my doctor who responded by saying she was knowledgeable about such adverse side effects and said that I should take Tylenol every 8 hours for the pain.  During the course of the week of July 31 - I experienced headaches, pain in my legs, total exhaustion and a poor appetite. The following week I was extremely tired, napped frequently, and was unable to perform my routine daily tasks which I take pleasure in doing.  Beginning on Aug. 12. I was able to resume multiple household tasks, cooking, hiking etc.  Unfortunately, I feel that I have lost ground which I can ill-afford to do.
This spontaneous report was received from a nurse practitioner refers to a 12 months female patient. The patient's medical history and current conditions were not specified. On 24-FEB-2014, the patient was vaccinated with VARIVAX (Merck) (lot # J004156, expiration date: 05-APR-2015) (first dose, 0.5 ml, subcutaneous). Concomitant medications were not specified. On 24-MAR-2014 (also reported as 4 weeks after administration of first dose) the patient stopped walking. The nurse reported that the patient was initially evaluated by an unspecified pediatrician but no diagnosis was made and no diagnostic testing was performed. The patient sought medical attention and visited the office. The nurse practitioner evaluated the patient in the office for the first time on 05-AUG-2014. The event patient stopped walking was considered as significant disability or incapacity. The outcome of the event was reported as not recovered. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
pt recvd vax; began rash day after admin; pt devel hives next day;
First dose: Fatigue, chills, muscle soreness, headache for three days after administration. Second dose: Fatigue, muscle soreness, headache for two days after administration. Itchy, red rash on right arm for 5 days after administration.
The injection site became red and reached a size of 2.5 inches. There was some initial swelling and pain in the armpit.
Mom notice large hot swelling at injection site on right arm measuring 8cm by 8cm.
This spontaneous report was received from a registered nurse refers to unknown number of patients (age and gender unknown). On 06-DEC-2012, the patients were vaccinated with a dose of improperly stored VARIVAX (Merck) (lot number H016600, expiration date on 05-SEP-2014) (route not reported) and on 19-DEC-2012, VARIVAX (Merck) (lot number H17705, expiration date on 25-SEP-2014) (route not reported). VARIVAX (Merck) were exposed in addition to 4 hours at room temperature and 45 hours at refrigerated temperature also exposed to 5.86 F to 15F for 5 minutes and it was doing this 3 times in 1 hour every day since the received dates of the VARIVAX (Merck). No adverse effect reported. This is one of the two reports received from the same reporter. Additional information has been requested.
I experienced an angioedema 30 hours after receiving the vaccine; woke up in the middle of the night with a swollen tongue and throat. I went to the ER and was immediately received injection of Benadryl and federal IV, and a skin Epi Pen. I was there for 10 hours for observation in the ER. I was given a prescription for Prednisone in decreasing doses to follow up with at home.
This case was reported by a consumer and described the occurrence of sore arm (injection site) in a subject of unspecified age and gender who was vaccinated with HAVIRX, (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent vaccination included HAVRIX; GlaxoSmithKline; unknown; unknown given in February 2013. In March 2013 the subject received 2nd dose of HAVRIX (unknown, right arm) and experienced sore arm (injection site) and drug dose administration interval too short. In late March 2013, the subject was administered a 2nd dose of HAVRIX one month after receiving the 1st vaccination. The reporter felt the clinic must have made a mistake. The subject felt uncomfortable after the second vaccination, clarified as soreness on the right arm that was different compared to the first vaccination. The reporter declined to provide specific details but authorized to be contacted for follow-up. At the time of reporting the outcome of the sore arm (injection site) was unspecified.
First dose: Bad for a couple of days; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, patient reported that first dose was bad for couple of days. Later she stated the first shot wasn't so bad, it was bad for a couple of days and went away. At the time of this report, the outcome of event was recovered.
Child began vomiting three hours post immunizations. Eyes "dropped" down-only whites of eyes visible-taken to ER-transferred to chop via ambulance-admitted for 2 days had spinal tap, EEG's, CT scan with neg results. ER record states seizure-like activity.
Fever with severe chills (body shaking) and fatigue that started around 12 hours after vaccine injection. Fever was on & off for 12 hours with chills. Fatigue lasted about 24 hours after shot.
Patient received Moderna dose 1 on 08/27/2021, Moderna dose 2 on 09/30/21 and a booster on 10/26/21. She is not immunocompromised. She received the booster shot less than 6 months after her 2nd vaccine.
Vaccine expired on 11/5/21, was given 11/7/21.  No adverse events reported.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 03-APR-2014 the patient was vaccinated with VARIVAX (lot# 0945AA, exp 14-JUN-2014). Route, dose and dose number were not reported. The dose of VARIVAX was expired. No adverse symptoms reported. The pharmacist mentioned "The expiration date on the label says '14 JUN 13', which is very confusing, because the person who administered the vaccine interpreted that as the product expired on June 13, 2014, not on June 14, 2013. The outcome of received an expired dose of VARIVAX and no adverse symptoms was unknown. Reporter causality assessment was not reported. Additional information has been requested.
Chest pain, heart palpatations, sharp pain in muscles throughout body, ringing in ears, bad headache, flu symptoms - most of which continue to be present 6 days after shot
Fever 102-105 starting the morning of 6/9 . Alternating Motrin and Tylenol every three hours until 6/10. Two episodes of vomiting around 11am on 6/9. Mild swelling noted left upper arm on 6/9. Site appeared normal on 6/10 per mom.
Patient had redness and pain at the injection site along with flu-like symptoms that lasted 3 days. Patient's husband received the same dose on the same day and did not have any reaction
redness & swelling in rt thigh;low grade fever to 100.5;fussy, vomiting, dec in appetite;
After the injection, she complained of heaviness in neck, dizziness, weakness. We lay her down, BP = 108/80 after 30 mins she was okay. She came back next day 5/2/07 with erythematic rash forehead and erythematic rash - small pustular (L) shoulder by (R) shoulder
Patient received a dose of 0.5 FLUZONE vaccine instead of a 0.25 FLUZONE.
Achy all over; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 77-year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date Feb2021 (Lot number: EL9264) at the age of 77 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Lot number: EL1283, arm left), administration date: Jan2021, when the patient was 77 years old, for COVID-19 immunisation, reaction(s): "Tiredness", "Headache", "Muscle pain", "Injection site red and hurting", "Injection site red and hurting", "it is still swollen, red, with a big red circle/size of 2 half dollars", "Hot to touch". The following information was reported: PAIN (non-serious) with onset 03Feb2021 21:00, outcome "unknown", described as "Achy all over".  Additional information: It was unknown if patient had prior vaccinations (within 4 weeks).  No follow-up attempts are possible. No further information is expected.
Patient is 33 week pregnant , estimated due date December. No reaction after the injection. Arm was sore at injection site that was gone after 1½ day then additional  during Sunday patient both hands/ fingers are very sore, does not hurt when stationary, but sore/stiff when curling fingers and holding things.
3h after receiving the first shot, I developed symmetric flank pain in the mid-thoracic area that persisted about 28 hours.  No CVA tenderness; elevated BP of 132/85; This is a spontaneous report from a contactable physician (patient). A 60-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686), via an unspecified route of administration on his left arm on 07Jan2021 18:00 at a single dose for COVID-19 immunization. Medical history was reported as none. Concomitant medications included acetylsalicylic acid (ASPIRIN [ACETYLSALICYLIC ACID]) and naproxen. Three hours after receiving the first shot (07Jan2021 at 22:00), patient developed symmetric flank pain in the mid-thoracic area that persisted about 28 hours. No CVA tenderness. The following morning, he had an elevated BP of 132/85 that persisted this morning (120/98). His normal BP is 110/70. Checked a creatinine and metabolic panel on 07Jan2021, all normal. There was no treatment received for the adverse events. The outcome of the events was recovering.
neuropathic pain; herpes zoster; Information has been received from a lawyer, regarding a case in litigation, and refers to a patient (pt) of unknown age and gender. No information about the pt's medical history, concurrent conditions and concomitant therapies was provided. On or about 06-JUL-2016, the pt was administered zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiration date were not provided) at a medical group for the long-term prevention of shingles and zoster-related conditions. Subsequently, on an unknown date, the pt was treated by a healthcare provider for the following injuries resulting from the pt's use of zoster vaccine live (ZOSTAVAX): herpes zoster and neuropathic pain. The outcome of the events was not reported. The reporter considered the events to be related to zoster vaccine live (ZOSTAVAX).
Patient describes developing right shoulder pain within 48 hours of receiving her 0.5mL FLUCELVAX (SEQ; lot#195248) IM to right deltoid, on 18 December 2017 that has been significant and persistent.  Patient does not recall exact location of vaccine administration, but does not recall receiving the vaccine high on the shoulder. She describes developing significant soreness at the vaccine site (without any observable swelling or redness) that progressed to stiffness and decreased range of motion that has persisted for more than 2 months. She describes the pain as a "dull achy pain" that can be 7 out of 10 in intensity with movement (especially internal rotation of the shoulder) and may be absent or minimal at rest. She notes decreased range of motion mostly with internal rotation. She has tried topical VOLTAREN GEL without any significant improvement. She has not, started any oral NSAIDs. She has not had any physical therapy to date. Workup by her PCM has included plain films and shoulder ultrasound that were reportedly unremarkable. She is currently pending an MRI of the shoulder. She has had a total of 3 PCM visits related to her shoulder pain thus far. Patient queries what can be done for this pain and how long will it last. Patient denies any other known adverse events following immunizations. And until now has received annual influenza vaccine without adverse events.
Feels asthmatic and tight in the chest. Has history of feeling anxious and feels similar to when she has had anxiety attacks Had highblood pressure 156/92 Has asthma and an inhaler and blood pressure medications EMS checked her breathing and all her vitals were good Wanted to hang out and rest and check in w/ her primary care provider Called her son to pick her up okay- rested
The patient awoke with extreme dizziness (room spinning) the night of receiving vaccines. The dizziness lasted throughout the next day. The patient also experienced some nausea with the dizziness.
non-stop throwing up; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (159558). The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), on 08Nov2021 as dose 1, single (Batch/Lot number: unknown) and in Nov2021 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VOMITING (non-serious) with onset Nov2021, outcome "not recovered", described as "non-stop throwing up". The event "non-stop throwing up" required physician office visit.  Additional information: Caller mentioned that she took her COVID-19 Vaccine shot last November and after getting vaccinated the caller stated that she had been non-stop throwing up and the doctor can't figure out what's wrong she is assuming that it came from the vaccine and she is having a side effect. As per caller she stated that she took her 1st dose 08Nov2021 and then the 2nd dose three weeks after. Suspected Pfizer Products:Product: Pfizer-Biontech COVID-19 Vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received dose on right arm . Patient had limited mobility on right arm so he went to hospital. Hospital determined the vaccine administer hit a nerve near the shoulder.
it was rpt by MD concerning pt w/history of varicella whose child was vax. 6 days later pt devel mild case of shingles due to poss vax transmission from pt child. rash resolved
Major rash over whole body from head to toes - very itchy - uncomfortable - taking benadryl